| Literature DB >> 34959515 |
Gustave Buname1, Gapto Aristides Kiwale2, Martha F Mushi2, Vitus Silago2, Peter Rambau3, Stephen E Mshana2.
Abstract
BACKGROUND: Tonsillitis is an inflammation of the tonsils due to either viruses or bacteria. Here, we report the bacteria patterns on the tonsillar surface and tonsillar core tissue among patients scheduled for tonsillectomy at Bugando Medical Centre (BMC), Mwanza Tanzania.Entities:
Keywords: Tanzania; bacteria; core; surface; tonsillar; tonsillectomy
Year: 2021 PMID: 34959515 PMCID: PMC8706977 DOI: 10.3390/pathogens10121560
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Social demographic and clinical data of 120 studied patients.
| Variable | Median/Frequency | * IQR/Percentage (%) |
|---|---|---|
|
| 6 | 4–11 |
|
| ||
| Male | 73 | 60.8 |
| Female | 47 | 39.2 |
|
| ||
| Rural | 22 | 18.3 |
| Urban | 98 | 81.7 |
|
| ||
| Uneducated | 3 | 2.5 |
| Primary | 19 | 15.8 |
| Secondary | 52 | 43.3 |
| University | 46 | 38.3 |
* IQR: Interquartile range.
Clinical characteristics and antibiotic use among study participants.
| Variable | Frequency | Percentage |
|---|---|---|
|
| ||
| Yes | 114 | 95.0 |
| No | 6 | 5.0 |
|
| ||
| Yes | 60 | 50.0 |
| No | 60 | 50.0 |
|
| ||
| Yes | 14 | 11.7 |
| No | 106 | 88.3 |
|
| ||
| Yes | 11 | 9.2 |
| No | 109 | 90.8 |
|
| ||
| Yes | 31 | 25.8 |
| No | 89 | 74.2 |
|
| ||
| Yes | 99 | 82.5 |
| No | 21 | 17.5 |
|
| ||
| Yes | 93 | 77.5 |
| No | 27 | 22.5 |
|
| ||
| Yes | 90 | 75.0 |
| No | 30 | 25.0 |
|
| ||
| Health care worker | 64 | 71.1 |
| Self | 26 | 28.9 |
|
| ||
| On symptom insert | 64 | 53.3 |
| Several days post infection | 32 | 26.7 |
| After drug failure | 24 | 20.0 |
|
| ||
| Yes | 29 | 24.2 |
| No | 91 | 75.8 |
* AMR is antimicrobial resistance.
Figure 1Type of medication used before tonsillectomy.
Sensitivity patterns of Gram-positive bacteria isolated from the surface and core tonsillar swab.
| Bacteria Isolated (n) | E n(%) | DA n(%) | LZD n(%) | SXT n(%) | CIP n(%) | CN n(%) | AK n(%) | FOX n(%) |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 14 (48.3) | 18 (62.1) | 4 (13.8) | 5 (17.2) | 15 (51.7) | 18 (62.1) | 23 (79.3) | 18 (62.1) | |
| 11 (64.7) | 12 (70.6) | 10 (58.8) | 0 (0.0) | 11 (64.7) | 14 (82.4) | 14 (82.4) | ||
| 2 (13.3) | 13 (86.7) | 14 (93.3) | 2 (13.3) | 10 (66.7) | 11 (73.3) | 12 (80) | ||
| 3 (75) | 3 (75) | 3 (75) | 3 (75) | 2 (50) | 2 (50) | 2 (50) | ||
| 2 (66.7) | 2 (66.7) | 2 (66.7) | 1 (33.3) | 3 (100) | 3 (100) | 2 (66.7) | ||
|
| ||||||||
| 9 (40.9) | 12 (54.5) | 12 (54.5) | 8 (36.4) | 13 (59.1) | 14 (63.6) | 15 (68.2) | 13 (59.1) | |
| 11 (91.7) | 6 (50.0) | 9 (75.0) | 0 (0.0) | 8 (66.7) | 9 (75.0) | 9 (75.0) | ||
| 3 (50.0) | 5 (83.3) | 4 (66.7) | 1 (16.7) | 2 (33.3) | 3 (50.0) | 3 (50.0) | ||
E—erythromycin, DA—clindamycin, LZD—linezolod, SXT—trimethoprim-sulfamethoxazole, CIP—ciprofloxacin, AK—amikacin, FOX—cefoxitin, CN-Gentamicin.
Figure 2(a) Hematoxylin and eosin tissue stain showing tonsillar squamous epithelium infiltrated by lymphocytes × 40. (b) Hematoxylin and eosin tissue stain showing variably sized follicles proliferation with prominent germinal centers, and fibrous tissue between the follicles × 4.
Figure 3Histology results if tonsillar tissue.